Persistent Asset Partners’s Revolution Medicines RVMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-461
Closed -$2.05K – 295
2025
Q2
$2.05K Buy
+461
New +$17.7K ﹤0.01% 177

Other funds holding RVMD

Persistent Asset Partners's RVMD Position: Q3 2026 in Review

Persistent Asset Partners reduced its Revolution Medicines (RVMD) stake by 47% in Q3 2026, selling an estimated $3.59M and leaving 20,609 shares worth $4.23M. The position accounts for 1.17% of the portfolio, ranked #18.

Persistent Asset Partners first reported a position in RVMD in Q2 2025 and has held it in 6 quarters since. The position peaked at $7.25M in Q2 2026. 758 funds tracked by Wall St. Rank hold RVMD as of Q3 2026.

  • Persistent Asset Partners held 20,609 shares of Revolution Medicines worth $4.23M as of Q3 2026.
  • Persistent Asset Partners sold 18,117 Revolution Medicines shares in Q3 2026, an estimated $3.59M.
  • Revolution Medicines made up 1.17% of Persistent Asset Partners's portfolio in Q3 2026, its #18 holding.
  • Persistent Asset Partners first reported a position in Revolution Medicines in Q2 2025 and has held it in 6 quarters since.
  • Persistent Asset Partners's Revolution Medicines position peaked at $7.25M in Q2 2026.
  • 758 funds tracked by Wall St. Rank held Revolution Medicines as of Q3 2026.

Based on Persistent Asset Partners's 13F filing for Q3 2026, filed 13 Nov 2026.